Duopharma Biotech Bhd (DPHARMA.KL) Stock Price
Duopharma Biotech Bhd Price
Over the last 19 years Duopharma Biotech Bhd grew revenue by 12.0% annually, reaching 813.70 M MYR. Earnings per share have grown at 0.8% per year over the last 19 years. For Duopharma Biotech Bhd, the net margin of 7.7% is down versus 10.3% a few years ago. At today's price the dividend yield works out to roughly 2.55%. The payout ratio is around 43% of earnings. The dividend has grown at 2.0% per year over the past 19 years. The consensus 12-month price target for Duopharma Biotech Bhd is 1.73 MYR, about 57.6% above where the stock trades today. Of 11 analysts, 10 rate the stock a buy — an overall Buy consensus.
Duopharma Biotech Bhd stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Duopharma Biotech Bhd business model & stock analysis
Frequently asked questions about Duopharma Biotech Bhd
Analysts currently set an average price target of 1.72 MYR for the Duopharma Biotech Bhd stock (median: 1.73 MYR), implying +56.3 % versus the latest price. The consensus is based on 11 analyst ratings.
11 analysts currently rate the Duopharma Biotech Bhd stock: 10 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Duopharma Biotech Bhd to generate revenue of 1.02 B MYR and earnings per share of 0.11 MYR.
Converted at the current exchange rate, the Duopharma Biotech Bhd share trades at 0.24 EUR (1.10 MYR).
The expected revenue of Duopharma Biotech Bhd is 1.02 B MYR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Duopharma Biotech Bhd is 103.61 M MYR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Duopharma Biotech Bhd is currently 10.21. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Duopharma Biotech Bhd stock.
The price-to-sales ratio (P/S) of Duopharma Biotech Bhd is currently 1.04. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Duopharma Biotech Bhd stock.
The Eulerpool Quality Score for Duopharma Biotech Bhd is 7/10.
The ISIN of Duopharma Biotech Bhd is MYL7148OO009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Duopharma Biotech Bhd is DPHARMA.KL. The ticker symbol is used to trade Duopharma Biotech Bhd shares on the stock exchange.
Duopharma Biotech Bhd stock
Duopharma Biotech Bhd Peer Group
Duopharma Biotech Bhd Ticker
Duopharma Biotech Bhd FIGI
All fundamentals and in-depth analysis of Duopharma Biotech Bhd
Our stock analysis for Duopharma Biotech Bhd stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Duopharma Biotech Bhd. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.